Skip to content

Evaluation of solid lipid nanoparticles containing Isotretinoin in treatment of acne

Study of clinical effects of solid lipid nanoparticles Isotretinoin in treatment of acne

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201203283862N9
Enrollment
30
Registered
2013-05-10
Start date
2011-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris. Acne

Interventions

Interventional group:receiving solid lipid nanoparticles (SLNs) containing 0.05% isotretinoin once a day for 8 weeks.
Intervention 1: Control group: receiving of 0.05% isotretinoin gel ( isotrex)
made in Irland. once a day for 8 weeks. Intervention 2: Interventional group:receiving solid lipid nanoparticles (SLNs) containing 0.05% isotretinoin once a day for 8 weeks.
Treatment - Drugs
Control group: receiving of 0.05% isotretinoin gel ( isotrex)
made in Irland. once a day for 8 weeks

Sponsors

Nano Technology Research Center,Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Acne vulgaris patients with grade 2 and 3 base on Investigator Global Assessment; No receiving topical treatment of acne from 4 weeks before this regimen. exclusion criteria:Androgenic acne;Acne due to drugs or cosmetics; Adrenal or Hormonal disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Inflammatory and non-inflamatory lesions. Timepoint: Biweekly after starting treatment. Method of measurement: Observation and calculating of elementary lesions based on photographic image.

Secondary

MeasureTime frame
Evaluation of side effects like skin irritation , erythema , skin dryness.pruritus. Timepoint: Biweekly. Method of measurement: Observation and severity scoring from + to +++.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDanial Bagheri

Nano Technology Research Center and faculty of pharmacy

bagherid851@mums.ac.ir+98 51 1882 3255

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026